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ABSTRACT
EVALUATING INTEREST IN CLINICAL TRIAL PARTICIPATION FOR THE
TREATMENT OF PEDIATRIC FOOD ALLERGY

Perry A. Catlin

Marquette University, 2022

Food allergy (FA) is a chronic medical condition that affects one out of every 13
children in the United States. Researchers have recently begun utilizing double-blind,
placebo-controlled clinical trials to test novel biological treatments designed to retrain the
immune system to be less reactive to food allergens. Although these treatments remain in
the clinical trial stage, evidence suggests that individuals differentially engage with these
options based on a variety of factors. Using a socioecological framework, this study
sought to evaluate the effect of child, parent, and family-level factors on parental interest
in clinical trial participation for the treatment of pediatric food allergy. Participants were
recruited from four pediatric specialty clinics across the United States. Results indicated
that child age was a reliable predictor of interest in clinical trial participation for both
Black and White parents of food allergic children. However, examination of parent
factors yielded mixed results with clear distinctions between racial groups. Interestingly,
none of the family factors examined were found to be significant. Interpretations and
conclusions are discussed.
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1
Evaluating Interest in Clinical Trial Participation for the
Treatment of Pediatric Food Allergy

Food allergy (FA) is a chronic medical condition that affects one out of every 13
children in the United States (R. S. Gupta et al., 2011). Symptoms of a food-induced
allergic reaction can range in severity from mild to life-threatening. Research has found
that adolescents and young adults are at increased likelihood of experiencing fatal foodinduced anaphylaxis (Turner et al., 2017). Hence, daily food allergy management can be
stressful for patients and their families, requiring considerable vigilance and careful
planning to avoid accidental exposure. Increased stress related to FA hypervigilance can
negatively impact family relationships and prompt parents to limit their child's social
activities, which contributes to impairments in food-allergy-related quality of life
(FAQoL; Warren et al., 2016).
Equally important are the observed disparities in the distribution of FA burden
across racial and socioeconomic strata. Notably, research has found that Black children
report higher rates of food-allergic sensitization (Branum & Lukacs, 2009; Liu et al.,
2010; Sicherer et al., 2010) and probable FA symptoms (Luccioli et al., 2008) compared
to non-Hispanic, White children. Similarly, greater FA prevalence rates have been
observed among urban- vs. rural-dwelling individuals (R. S. Gupta et al., 2012). The
financial impact of FA also disproportionately affects low-income families, who report
spending nearly twice as much on food allergy-related emergency department (ED) visits
and hospitalizations than other income groups (Bilaver et al., 2016). These findings
suggest that the public health burden of FA is in its prevalence and management.
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Existing guidelines for FA management are quite limited and do not sufficiently
protect patients from the threat of accidental exposure. In recognition of this,
investigators have begun testing novel treatments designed to reduce an affected
individual's natural biological response to food allergens. In turn, these treatments can
also decrease the emotional and financial toll associated with the condition. However, to
ensure the safety and efficacy of these novel treatment modalities, participants in these
clinical trials should reflect the full diversity of the affected population. Despite this, we
continue to see disproportionate clinical trial participation rates among low-income and
minority patients across all disease groups. In addition, literature on factors that influence
participation in food allergy-specific clinical trials is sparse. However, medical decisionmaking literature in other populations was reviewed to identify potential child, parent,
and family-level factors that may influence clinical trial participation in pediatric food
allergy.
Food Allergy Overview
In 2004, the United States Congress passed the Food Allergy Labeling and
Consumer Protection Act, identifying eight common food allergens: milk, eggs, fish,
shellfish, tree nuts, peanuts, wheat, and soybean. Since the enactment of this law, the
United States has seen a steady increase in FA prevalence among children (R. S. Gupta et
al., 2011). A population-based study conducted between 2007 and 2010 found that
roughly 6.5% of children reported having food allergies (McGowan & Keet, 2013).
Food-induced allergic reactions are harmful immune responses that often occur within 20
minutes after initial exposure. The most severe type of food-induced allergic reaction is
anaphylaxis, characterized by multiple acute severe symptoms (i.e., hives, vomiting,
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wheezing) reported within multiple organ systems (i.e., skin, gastrointestinal,
respiratory). Epidemiological research suggests that 40-50% of children diagnosed with
FA have experienced at least one severe, life-threatening allergic reaction resulting in a
trip to the ED (R. S. Gupta et al., 2011, 2018). Between 2008 and 2012, another study
found that ED visits and hospitalization due to anaphylaxis spiked 29.1% annually among
children (Dyer et al., 2015). Although it is challenging to predict who is at the greatest
risk of anaphylaxis, it is essential to note that many people practice strict avoidance of
suspected food allergens, despite not reporting convincing FA symptomatology.
Consequently, these individuals are likely to experience strained family relationships,
impaired quality of life, and additional economic burdens associated with chronic food
allergy management (Warren et al., 2016).
Due to the ubiquity of most food allergens and the small amounts needed to
induce a reaction, parents of food-allergic children must know the signs and symptoms of
allergic reactions. In addition, in some instances, parents may need to respond quickly to
emergent allergy situations that require the performance of appropriate life-saving
measures. However, one study examining caregiver experiences following their child's
first food-induced allergic reaction identified significant gaps in FA knowledge leading to
increased fear and anxiety of future reactions (Abdurrahman et al., 2013). Specifically,
Abdurrahman et al. (2013) found that caregivers displayed insufficient knowledge of
using epinephrine auto-injectors (EpiPen) and a diminished sense of self-efficacy related
to managing their child's food allergy. As a result, 94% of caregivers endorsed making
social lifestyle changes to avoid future reactions (Abdurrahman et al., 2013). Additional
studies have reported impaired FAQoL related to the total number of food allergies and
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the patient's overall history with the condition (Allen et al., 2015). Notably, patients with
a greater number of food allergies report lower FAQoL than those with fewer food
allergies (Allen et al., 2015; Howe et al., 2014; Wassenberg et al., 2012). Also, FAQoL
appears to be worse among caregivers of food-allergic children who report a history of
severe food allergic reactions, a greater number of symptoms during a previously
reported food allergic reaction, and any previous epinephrine use (Allen et al., 2015;
Chow et al., 2015; Howe et al., 2014). These findings suggest that daily food allergy
management stress is compounded by the degree of vigilance required for allergen
avoidance and the resulting impact on family social functioning.
Observed Disparities in FA Across Racial and Socioeconomic Strata
Given FA's significant population health burden, it is necessary to address the
observed disparities in its prevalence, management, and outcomes. A review of the extant
FA literature revealed striking differences in the distribution of FA burden across racial
and socioeconomic strata (Warren et al., 2021). For example, data from a recent
population-based study indicate that White adults report lower rates of FA relative to
their Black, Hispanic, Asian, and multiracial counterparts (R. S. Gupta et al., 2019).
Additionally, this study found that prevalence rates appear to be similar among adults in
the highest and lowest income strata (R. S. Gupta et al., 2019). In another study
controlling for age, findings suggested that the prevalence of food sensitization among
Black Americans was 27% compared to 13.8% for White Americans (Liu et al., 2010).
Research has also identified food-specific disparities in allergic sensitization. For
example, one study found that Black adults reported higher rates of seafood allergy than
other racial/ethnic groups (Sicherer et al., 2004). Additionally, Black children are
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reported to be at nearly two-fold risk of being allergic to any food compared to White
children (R. S. Gupta et al., 2011). However, Black children report greater FA
sensitization, specifically to peanuts (Sicherer et al., 2010), milk, egg, and shrimp
(Branum & Lukacs, 2009; Liu et al., 2010). Interestingly, research suggests that children
who receive a physician-diagnosed peanut-, tree-nut, shellfish, and/or finfish allergy are
more likely to have a positive history of at least one severe reaction compared to children
with other allergies (R. S. Gupta et al., 2018, 2019).
Although Black children report higher rates of probably FA symptoms than White
and Hispanic children (Luccioli et al., 2008), minority and low-income children who
meet symptom criteria are less likely to report a physician diagnosis (R. S. Gupta et al.,
2011). Results of a Detroit-based cohort study suggest that the observed difference in
rates of food-allergic sensitization may contribute to disproportionate rates of physiciandiagnosed food allergies observed among Black and White children (R. S. Gupta et al.,
2018; Joseph et al., 2016). This research is further supported by studies citing issues
related to under-diagnosis and/or inadequate access to specialty care for FA among urban
minority children (Taylor-Black & Wang, 2012).
Daily food allergy management is also more challenging for minority and lowincome families. In particular, Black adults with FA report higher rates of severe allergic
reactions and FA-related ED visits than White adults (R. S. Gupta et al., 2018, 2019).
Further, Gupta et al. (2018) identified a similar trend among Black and Hispanic children.
Notably, studies have found that Black and Hispanic parents are less likely to correctly
identify signs of FA reactions and potential triggers (R. S. Gupta, Kim, Springston,
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Smith, et al., 2009). Thus, inadequate access to specialty care and insufficient knowledge
of FA signs and symptoms can exacerbate existing disparities in FA health outcomes.
The financial impact associated with managing FA can also take a significant toll
on patients and families. A study describing the economic impact of childhood FA in the
United States found that the annual economic cost was estimated to be $24.8 billion,
equating to roughly $4,184 per year per child (R. Gupta et al., 2013). This study also
found that the annual direct medical costs associated with hospitalizations, clinician
visits, and ED visits were roughly $4.3 billion (R. Gupta et al., 2013). At a more granular
level, costs that directly affected families (such as lost labor, out-of-pocket, and
opportunity costs) were estimated to be roughly $20.5 billion annually (R. Gupta et al.,
2013). These findings are even more alarming when race and SES are considered. Food
allergy-related ED visits and hospitalization disproportionately affect families of foodallergic children in the lowest income bracket, who routinely spend more than twice as
much as other income groups (Bilaver et al., 2016). Furthermore, a report on urban
hospital networks in Chicago and Cincinnati found elevated rates of food-induced
anaphylaxis and related ED visits among Black children with FA relative to nonHispanic, White children (Mahdavinia et al., 2017). Given these findings, it appears that
the pipeline from sensitization to physician-diagnosed food allergy, and the associated
burdens of that diagnosis, disproportionally affects Black children and their families.
Treatment Options for Food Allergy
Avoidance
Expert guidelines for FA management advise strict avoidance of all products
containing potential food allergens (Boyce et al., 2010; Togias et al., 2017). However,
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adherence to strict avoidance does not always prevent accidental exposures. Though strict
avoidance may be most effective in reducing the potential for accidental exposure, it
engenders a risk-averse approach to FA management and does not adequately account for
families that may experience food insecurity. Low-income families who experience
difficulty meeting basic nutritional needs often have limited control over their food
selection. One study found that families of food allergic children who experience food
insecurity report a greater perceived risk of accidental ingestion than families who did not
report food insecurity (Tackett et al., 2018). Another study revealed that food-allergic
children from low-income families account for nearly 2.5 times more ED and
hospitalization costs than those from high-income families (Bilaver et al., 2016). This
study also found that low-income families spend significantly less on specialty healthcare
services for FA than higher-income families (Bilaver et al., 2016). Together, these
findings highlight an over-utilization of emergency services among low-income
community members, exacerbating existing financial disparities.
Furthermore, strict avoidance does little to address a parent’s fear of accidental
exposure. Research has shown that parents of food-allergic children experience elevated
levels of stress and anxiety, which can be attributed to the constant need to avoid all
food-allergen-containing products and the chronic threat of potential anaphylaxis
(Primeau et al., 2000; Warren et al., 2016). Parents' perception of threat is a significant
predictor of FA-related anxiety and is negatively associated with parental confidence in
their ability to manage their child's FA (Roberts et al., 2021). Aside from strict
avoidance, managing food allergies is generally limited to medication management,
immunotherapy, or clinical trials. Each option proposes a certain level of risk and
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potential benefit inherent to treating and managing food allergies. It is recommended that
individuals use over-the-counter or prescribed medications, like diphenhydramine or
other antihistamines, to reduce symptoms of a minor allergic reaction (Boyce et al., 2010;
Togias et al., 2017). Individuals with more severe food allergies are further advised to
carry an epinephrine auto injector for use in case of emergencies. The problem with
medication management in FA is that this approach requires a reaction to occur and does
not provide any preventative assurance against potential adverse reactions.
Immunotherapy
Allergen immunotherapy has been widely practiced for hundred of years.
Immunotherapy more recently has been applied to treat food allergy. Research has
demonstrated the safety and efficacy of FA immunotherapy (Vickery et al., 2017). The
technique of oral immunotherapy (OIT) is a voluntary, FDA-approved treatment option
designed to strengthen the body's immune system to tolerate small doses of allergenic
foods. Studies have determined that OIT for patients with peanut allergies can safely
desensitize an individual to a whole peanut (~300 mg peanut protein), which doctors
propose will likely provide adequate protection against most accidental peanut exposures
(Vickery et al., 2017). For most patients, peanut OIT has not been shown to be a curative
therapy. While immunotherapy is a promising new direction in FA treatment, parents
must make an informed decision when evaluating this treatment option considering the
importance of adherence to at-home dosing. Thus, this option may not be best suited for
all patients and families.
The prevalence of FA, the potential danger of accidental exposures, and the
resulting stress on patients and families highlight the significant public health burden
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related to FA management in children. As a result, healthcare researchers must begin
studying novel treatment modalities that can safeguard food-allergic children from the
possibility of severe allergic reactions and provide patients and their families with the
mental security of immunological protection. It’s equally important to consider how
parents evaluate these options when they are available.
Clinical Trials Overview
Currently, there is no cure for FA. However, in recent years, health researchers
have begun utilizing double-blind, placebo-controlled clinical trials to test novel
biological treatments designed to retrain the immune system to be less reactive to food
allergens. In general, clinical trials are a type of clinical study that evaluates the effects of
novel interventions on relevant biobehavioral health outcomes. Clinical trials for food
allergies have the potential to advance medical understanding of food allergy phenotypes
and how the condition responds to novel treatment modalities. Given the inherent risks
associated with participating in a clinical trial designed to test the effectiveness of
experimental products, treatment-related decision-making for these patients and families
can be difficult. Further, uncertainty related to treatment outcomes can impede a family's
ability to make informed decisions about medical care. To ensure the safety and efficacy
of these emerging therapies, participants in clinical trials must reflect the full diversity of
the affected population. Although these treatments remain in the clinical trial stage,
evidence suggests that individuals differentially engage with these options for a variety of
reasons.
Factors Associated with Clinical Trial Participation
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Medical decision-making can be complex, especially when multiple treatment
options are presented (Redelmeier & Shafir, 1995; Reyna, 2008). Thus, treatment-related
decision-making for children with FA requires significant consideration of each
treatment's potential costs and benefits, and subjective factors that may influence
decision-related outcomes. Currently, there is a paucity of research on how interacting
family systems influence parent-led medical decisions in the FA population. However,
medical decision-making literature from other populations can help to determine the
potential affect various family systems on clinical trial participation for the treatment of
pediatric FA.
Child Age
One consideration that parents often make when evaluating treatment options is
the age of the child. In a study evaluating enrollment decisions for a randomized
controlled trial, researchers found that parents of slightly older children were more likely
to consent (Hoberman et al., 2013). In another study evaluating trial participation
decisions, the age of the child (≥4 years) was significantly associated with consent
(Sureshkumar et al., 2012), suggesting that parents of older children are more likely to
consent to this study than parents of younger children. Thus, child age may be a factor
that influences parents of older food-allergic children to participate in clinical trials.
Importantly, the presence of a relationship between race and child age has not been
previously explored in the literature, therefore justifying research into this area.
Parental Knowledge
Previous studies exploring parent treatment preferences found that roughly 50%
of respondents felt more comfortable enrolling their child in a trial that involves a drug or
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device currently used in their physician's practice (Hoffman et al., 2007). Similar to this
study, Dreyzin et al. (2014) found that families were more hesitant to participate in
clinical trials with unknown risks. Families in this study also felt less confident in their
ability to aptly evaluate different treatment modalities (Dreyzin et al., 2014). Together,
these studies highlight the salience of condition-specific knowledge and treatment
familiarity among decision-making stakeholders. For parents of food allergic children,
FA management requires sufficient knowledge of allergic symptoms and treatment
recommendations. As such, parents with greater FA knowledge may have less difficulty
evaluating the risks and benefits of novel treatment modalities. However, given existing
disparities in FA knowledge, evaluating treatment options may be more difficult for
racial and ethnic minority families and therefore result in less interest in clinical trial
participation.
Parental Health Beliefs
The likelihood of a parent engaging in a specific health behavior, such as
enrollment in a clinical trial, largely depends on their perception of the severity of their
child’s condition, and their ability to manage it. For example, one study found that
parents who perceive their child’s condition as more severe expressed greater willingness
to enroll in a clinical trial to treat sickle cell disease (Liem et al., 2010). Currently, there
is limited empirical evidence on the relationship between parental health beliefs and
medical decision-making in the food allergy population. Two studies found that parental
confidence in their ability to manage their child’s food allergy was associated with lower
perceived likelihood of having a severe allergic reaction (Knibb et al., 2015, 2016).
Given this finding, we expect parents who express greater self-efficacy may be less
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interested in participating in clinical trials for FA. In another study specifically evaluating
clinical trial participation, parents who decided to participate in a clinical trial for food
allergy perceived that their child was more likely to have a severe allergic reaction that
could be fatal (DunnGalvin et al., 2009). Thus, families who perceive their child’s food
allergy as more severe may express greater interest in clinical trial participation.
Quality of Life
Health is a dynamic phenomenon influenced by physical, psychological, and
social factors. The extent to which these factors change over time can impact how a
parent perceives their child’s quality of life, and subsequently influence their decisions
about medical care. Compared to healthcare professionals, parents tend to weigh the
child’s quality of life more heavily when evaluating treatment options (Janse et al., 2005;
Tomlinson et al., 2011). For example, parents of children with life-limiting conditions
often strongly consider their child’s quality of life over the potential for improved health
or prolonged life expectancy when making decisions about the care and treatment of their
child (Hinds et al., 1997; Markward et al., 2013; Maurer et al., 2010). In the FA
population, research has revealed a diminished quality of life among older children,
children with multiple food allergies, and children with a history of severe allergic
reactions (Wassenberg et al., 2012). Given the significant burden associated with having
a FA, it is essential to capture the extent to which parents of food allergic children
consider the quality of life when evaluating treatment options for FA. As such, the
decision to participate in different treatment options may depend on how parents perceive
their child’s health, their quality of life, and the effect treatment may have on the family
overall.
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Race
Racial diversity in clinical research is essential for the generalizability of research
findings (Hussain-Gambles et al., 2004; Yancey et al., 2006) and the equitable
distribution of health services (Davis et al., 1985). However, studies have highlighted
disparate clinical trial participation rates among Black families (Ni et al., 2016). This
reality stems from interpersonal and pragmatic barriers that have impacted Black
Americans perceptions of health research and their willingness to participate in clinical
trials (Freimuth et al., 2001; Shavers et al., 2002). Specifically, Black Americans have
called the integrity of the research institution into question by expressing concerns related
to data use (Freimuth et al., 2001), improper treatment of Black research participants
(Corbie-Smith et al., 2002), improper consent procedures (Farmer et al., 2007), and the
disclosure of private health information (Slomka et al., 2008). Furthermore, studies have
found that concerns about the lack of choice over treatment in clinical trials have
negatively impacted Black Americans' willingness to participate in health research
(Linden et al., 2007). Together, these factors have contributed to the underutilization of
health services and the underrepresentation of Black participants in medical research.
Socioeconomic Status
Scarcity and/or lack of resources can significantly impact treatment-related
decisions about a child’s medical care (Shafir, 2017; Shah et al., 2015). In a study
evaluating clinical trial participation, researchers identified disparate clinical trial
participation rates among families living in poverty (Ni et al., 2016). This finding
highlights the potential barriers to clinical trial participation that may stem from
insufficient access to specialty care and information about different treatment options.
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It is also important to acknowledge how systemic reactions to race have led to
significant pragmatic barriers for Black patients and families. Researchers often conflate
being Black with being impoverished. Studies have shown that physicians who possess
implicit biases that label Black patients as being medical uncopperative often hesitate to
recruit these patients into clinical trials (Kaluzny et al., 1993; Oliver et al., 2014). Taken
together, the effect of poverty on illness management and participation in health research
can be considered a difference of kind rather than degree when race is considered. In
recognition of the various interpersonal and pragmatic barriers Black families of foodallergic children may face, it is necessary to explore how these factors influence parental
interest in clinical trial participation.
Insurance Status
Insurance status is often used as an indicator of socioeconomic status, and
therefore should be considered in pediatric medical decision-making. Researchers found
that individuals with private health insurance were less likely to enroll their children in a
clinical trial (Hoberman et al., 2013). Conversely, another study revealed having public
health insurance was associated with an increased likelihood of allowing one's child to
participate in medical research (Svensson et al., 2012). These findings suggest that health
insurance status may influence parental interest in clinical trial participation. However, to
date, this relationship has not been explored in the food allergy population. Given the
existing literature, parents of food allergic children with public health insurance may to
be more interested in clinical trial participation. Additionally, given the demographic
make-up of families who are uninsured, publicly insured, and privately insured, it is
necessary to explore racial differences across these categories.
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Education
Educational attainment is important to consider when evaluating different
treatment options and the risks and benefits. Studies have reported having a college
degree decreased parents’ likelihood of enrolling thier child in a clinical trial (Hoberman
et al., 2013). Similarly, another study indicated that low educational attainment was
positively associated with a greater likelihood of allowing one's child to participate in
medical research (Svensson et al., 2012). Thus, the relationship between parental
educational attainment and clinical trial participation may be an important factor to
explore in the context of pediatric food allergy. Again, given the racial disparities in
educational attainment, it is necessary to evaluate this factor across racial groups as well.
Summary and Aims
Purpose
Treatment-related decision-making for children with FA requires significant
consideration of the potential costs and benefits of treatment and subjective factors that
may influence decision-related outcomes. Currently, there is a paucity of research on
factors may influence parent-led medical decisions in the FA population. Therefore, this
study sought to explore the interrelated factors that may influence interest in clinical trial
participation for the treatment of pediatric FA. This study has the potential to add to the
literature by evaluating the differential effects of child, parent, and family-level factors on
interest in clinical trial participation, while also explicitly examining the role of race and
socioeconomic status in the analyses.
Specific Aims
The aims and hypotheses of this study are:

16
Aim 1: Child Factors
Evaluate the effect of child age on parental interest in clinical trial participation
among Black and White caregivers. Working hypothesis for Aim 1: Parents of older
children will report greater interest in having their child participate in a clinical trial to
treat food allergy, regardless of race.
Aim 1a. Evaluate the effect of child age on parental interest in clinical trial
participation among the entire sample combining Black and White caregivers.
Aim 1b. Evaluate the effect of child age on parental interest in clinical trial
participation among Black caregivers.
Aim 1c. Evaluate the effect of child age on parental interest in clinical trial
participation among White caregivers.
Aim 2: Parent Factors
Evaluate the effect of parent FA knowledge, perceived burden, self-efficacy,
quality of life, and perceived risk of accidental exposure on parental interest in clinical
trial participation among Black and White caregivers. Working Hypothesis for Aim 2:
Parents with greater FA knowledge, greater perceived burden, less confidence in their
ability to manage their child’s food allergy, impaired quality of life, and greater perceived
risk of accidental exposure will report greater levels of interest in having their child
participate in a clinical trial to treat food allergy. Specific race effects will be evident
between Black and White caregivers.
Aim 2a. Evaluate the effect of parent FA knowledge, perceived burden, selfefficacy, quality of life, and perceived risk of accidental exposure on parental interest in
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clinical trial participation among the entire sample combining Black and White
caregivers.
Aim 2b. Evaluate the effect of parent FA knowledge, perceived burden, selfefficacy, quality of life, and perceived risk of accidental exposure on parental interest in
clinical trial participation among Black caregivers.
Aim 2c. Evaluate the effect of parent FA knowledge, perceived burden, selfefficacy, quality of life, and perceived risk of accidental exposure on parental interest in
clinical trial participation among White caregivers.
Aim 3: Family Factors
Evaluate the effect of family-level factors on parental interest in clinical trial
participation among Black and White caregivers. Working hypothesis for Aim 3:
Families with >1 child with FA will report greater interest in having their child
participate in a clinical trial to treat food allergy than families with only one child with
FA. Families who receive public health insurance will report greater interest in having
their child participate in a clinical trial for the treatment of food allergy than families who
receive private insurance. Additionally, uninsured and low-SES families will report lower
levels of interest in having their child participate in a clinical trial to treat food allergy.
Finally, families with higher educational attainment will report less interest in having
their child participate in a clinical trial to treat food allergies than families with lower
educational attainment. Specific race effects will be evident between Black and White
caregiver respondents.
Aim 3a. Evaluate the effect of family-level factors on parental interest in clinical
trial participation among the entire sample combining Black and White caregivers.
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Aim 3b. Evaluate the effect of family-level factors on parental interest in clinical
trial participation among Black caregivers.
Aim 3c. Evaluate the effect of family-level factors on parental interest in clinical
trial participation among White caregivers.
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Methods

Participating Sites
The study employed a prospective design to identify factors associated with
parents' interest in clinical trial participation to treat pediatric FA. The study subsumed
under a more extensive parent study funded through the NIH (The FORWARD study:
5R01AI130348-04 to PI – Ruchi Gupta). Recruitment was conducted at four pediatric FA
clinics across the United States: Lurie Children's Hospital, Cincinnati Children's Hospital
Medical Center (CCHMC), Rush University Medical Center, and Children's National
Health System. These sites are world-renowned pediatric FA clinics with inpatient and
outpatient Allergy/Immunology services and a strong history of research collaboration. In
addition, each hospital operates on an integrated electronic medical record (EMR) system
and serve diverse populations with a mix of privately and publicly insured (or uninsured)
patients in and around their respective locations. Together, these institutions serve over
15,000 patients annually; thus, the annual patient volume supported enrollment for the
study.
Participants
Participants included patients and families seeking services at one of the four
pediatric FA clinics mentioned above. Individuals eligible to participate in the
FORWARD study met the following criteria: 1) New clinic visit presenting for a
possible peanut allergy complaint and/or has a physician diagnosis in a follow-up clinic
visit; 2) child is between the age of 6-months and 12 years at intake visit; 3) are English
speaking, and 4) no history of developmental disorders. Parents provided written
informed consent using procedures approved by the Institutional Review Board at
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Northwestern University (NU). An initial intake survey was administered at the time of
enrollment, and parents completed quarterly follow-up REDCap surveys via text, email,
or phone based on their stated preference.
Marquette University's Institutional Review Board approved the study. Data for
this study was extracted by study staff at Northwestern, de-identified, and transferred via
a secure, electronic medium. Each participating site signed a reliance and data-sharing
agreement, and PIs at each site consented to share data with the investigator.
Measures & Sources of Patient Information
Intake Survey
The intake survey was developed by an expert panel of pediatric allergists and
designed by survey methodologists. Basic demographic information was collected—
including child age, race/ethnicity, income, education level, and employment status. Food
allergy-specific information was also collected, including the number of children with
food allergies in the household, history of allergic reactions, severe allergic symptoms,
and food allergy management practices. This questionnaire also assessed families'
interest in participating in a clinical trial for FA, using a single variable with five
response options: 1) Not At All Interested, 2) Slightly Interested, 3) Somewhat Interested,
4) Very Interested, and 5) Extremely Interested. The present study combined these
responses to create three interest groups: 1) Not At All Interested, 2) Slightly/Somewhat
Interested, and 3) Very/Extremely Interested.
Electronic Health Record
Trained research assistants extracted electronic medical record data to confirm FA
diagnosis, patient age at the time of recruitment, and health insurance status for each
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child. Health insurance status was stratified by those insured proximal to the study
enrollment visit vs. those uninsured. For individuals with health insurance, coverage was
further stratified by privately and publicly insured.
Chicago Food Allergy Research Survey for Parents of Children with Food Allergy
(CFARS-PRNT; R. S. Gupta, Kim, Springston, Pongracic, et al., 2009).
Parental food allergy knowledge was assessed using the Food Allergy Knowledge
subscale of the CFARS-PRNT. The Food Allergy Knowledge subscale measure is 15
items (eight true/false, seven multiple choice). Higher scores indicate greater FA
knowledge. This measure was assessed at the 6-month timepoint of the FORWARD
study. The present study found this scale to demonstrate moderate internal consistency
(Cronbach’s α = .56).
Food Allergy Self-Efficacy Scale for Parents (FASE-P; Knibb et al., 2015).
The FASE-P is a validated 21-item measure designed to assess caregiver
confidence (self-efficacy) in their ability to manage their child’s food allergy. The
FASE-P has five subscales: 1) managing social activities, 2) precaution and prevention of
an allergic reaction, 3) Identifying allergens, 4) treating an allergic reaction, and 5)
seeking information about food allergy. The FASE-P is scored on a 0-100 scale, with
higher scores indicating greater confidence in their ability to manage their child’s food
allergy. The FASE-P has previously demonstrated good internal consistency (Pappalardo
et al., 2022; Cronbach’s α = .89). The present study also found this scale to demonstrate
good internal consistency (Cronbach’s α = .90).
Food Allergy Quality of Life Questionnaire-Parent Form (FAQLQ-PF-10; Moynihan et
al., 2015).
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The FAQLQ-PF-10 is a 10-item short form of the Food Allergy Quality of Life
Questionnaire, that assesses the health-related quality of life (HRQoL) of children with
food allergies. It is completed by the parent of a food-allergic child, and rated on a 7point scale ranging from 1 (not at all) to 7 (extremely). Higher FAQLQ-PF-10 scores
indicate a more significant negative impact on HRQoL. The present study found this
scale to demonstrate excellent internal consistency (Cronbach’s α = .91).
The Food Allergy Quality of Life – Parental Burden (FAQL-PB; Knibb & Stalker,
2013).
The FAQL-PB is a validated 17-item scale designed to assess how troubled
parents are by certain aspects of their child's food allergy. Questions cover issues related
to going on vacation, participating in social activities, and worries and anxieties over the
previous week. Higher scores indicate more significant parental burden associated with
their child’s food allergy. The FAQL-PB has previously demonstrated excellent internal
consistency (Pappalardo et al., 2022; Cronbach’s α = .96). The present study also found
this scale to demonstrate excellent internal consistency (Cronbach’s α = .96).
Food Allergy Independent Measure (FAIM; Van Der Velde et al., 2010).
The FAIM is a validated six-item measure that assesses parents’ perceived risk of
adverse FA outcomes. Each item is rated on a 7-point Likert scale with higher scores
indicating greater perceived risk of adverse FA outcomes. The FAIM has previously
demonstrated good internal consistency (Pappalardo et al., 2022; Cronbach’s α = .81).
The present study found this scale to demonstrate good internal consistency (Cronbach’s
α = .78).
Analyses
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Data was collected from The FORWARD Study (5R01AI130348-04) and
assembled into a dataset that included the following sources: electronic medical record
(EMR), Intake Survey, Parental Food Allergy Knowledge Scale, Food Allergy SelfEfficacy Scale, Food Allergy Quality of Life-Parental Burden, and Food Allergy Quality
of Life Questionnaire, the Food Allergy Independent Measure; all data was de-identified
before transfer. Locally, the dataset was stored on a secure, password-protected external
hard drive. Missing data was addressed using full information, maximum likelihood
multiple imputations, and limited to no more than 5% of the data.
Aims were examined via six discriminant function analyses (DFA) and three
multinomial logistic regressions (MLR). In DFA, the independent variables are the
predictors, and the dependent variable is group levels. For the DFA analyses, a single
intake variable indicating interest in clinical trial participation for the treatment of
pediatric FA served as the DV, with three (3) levels or groups. Families were grouped
into the following "interest categories" based on their responses: 1) Not At All Interested,
2) Slightly/Somewhat Interested, and 3) Very/Extremely Interested. For Aim 1, the only
child variable used to predict interest group membership was child age (intake survey).
Analysis of aim 1 was run three times to evaluate the effect of the child variable in the
full dataset and differences between Black and White participants. For Aim 2, parent
variables used to predict interest group membership were: parental FA knowledge (Food
Allergy Knowledge Scale), FA self-efficacy (Food Allergy Self-Efficacy; FASE),
parents’ perceived risk of adverse FA outcomes (Food Allergy Independent Measure;
FAIM), FA-related quality of life (FAQLQ-PF-10), and perceived parental burden (FA
Quality of Life-Parental Burden). Analysis of aim 2 was performed three times to
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evaluate the effect of parent variables in the full dataset and differences between Black
and White participants.
The same intake variable was used in the MLR analyses to examine the ability of
family-level (Aim 3) variables to predict interest group membership. MLR was used
(instead of DFA) because this type of analysis is more appropriate for categorical,
ordinal, and continuous predictor variables. For Aim 3, family variables used to predict
interest group membership were: the number of children with FA in the home (intake
survey), insurance status (EMR), income (Intake Survey), and education level (intake
survey). Analysis of aim 3 was performed three times to evaluate effect of family-level
variables in the full dataset and differences between Black and White participants.
Power for DFA was calculated via power calculations for MANOVA, as DFA is
considered the reverse of MANOVA, and the calculations are essentially the same
(Tabachnick & Fidell, 2018). An a priori power estimate in GPower 3.1.9, with Cohen's
f set to a .1 small effect size, .05 alpha, power of .95, three groups/levels of FA trial
interest, and three response variables, indicated that 85 total participants would be
necessary for adequate power.
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Results

Participant Demographics
Overall, 859 participants in the FORWARD study were assessed for eligibility.
Figure 1 displays a consort diagram of eligible participants that were included in the
present study. Of note, n = 188 FORWARD participants were excluded for either not
reporting on the Interest variable (n = 151) or identifying with a race other than Black or
White (n = 37). This retained a final sample of N = 671 for data analyses.

Figure 1
Consort diagram of eligible participants.

Assessed for
eligibility (n = 859)

Excluded (n = 188)
- Did not report Interest
Variable (n = 151)
- Race other than AA or
White (n = 37)

Final dataset (N = 671)
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The overall sociodemographic characteristics of the sample are displayed in Table
1. 53.1% of parents reported being Very/Extremely Interested in clinical trial
participation, followed by 40.2% reporting being Somewhat/Slightly Interested and 6.7%
being Not At All Interested. The racial composition of the sample was 65.7% White and
34.3% Black. Overall, there was a relatively even educational and income distribution.
Additionally, participants were evenly distributed across all participating sites, and were
primarily covered by either public or private insurance.

Table 1
Sociodemographic Characteristics of Participants
Characteristic
Interest in Clinical Trial Participation
Not At All Interested
Slightly/Somewhat Interested
Very/Extremely Interested
Race
White or Caucasian
Black or African American
Level of Education
Some H.S., No Diploma
H.S. Graduate, Diploma or Equivalent
Some College, No Degree
Associates
Bachelor’s
Master’s
Professional Degree
Doctorate
Annual Household Income
Less than $50,000
$50,000 – $99,000
$100,000 – $149,000
$150,000 – $199,000
$200,000 – $299,000
$300,000 or More
Unreported
Site
NU

N

%

45
270
356

6.7
40.2
53.1

441
230

65.7
34.3

9
45
103
46
179
197
25
67

1.3
6.7
15.4
6.9
26.7
29.4
3.7
10

163
100
106
63
90
87
62

24.3
14.9
15.8
9.4
13.4
13
9.2

224

33.4
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CCHMC
165
24.6
RUMC
123
18.3
CNH
159
23.7
Insurance Type
Public
157
23.4
Private
472
70.3
Tricare or Other Military Insurance
3
.4
No Insurance
3
.4
Not Specified
1
.1
Note. H.S = High School; NU = Northwestern University; CCHMC = Cincinnati
Children’s Hospital Medical Center; RUMC = Rush University Medical Center; CNH =
Children’s National Hospital.

Aim 1: Child Factors
Child Factors (Overall Sample)
Discriminant analysis was used to determine if child age predicted interest group
membership. Interest groups included: Not at All Interested, Slightly/Somewhat
Interested, and Very/Extremely Interested in clinical trial participation. The mean age of
children in the overall sample was 5.32 years with a standard deviation of 3.65 years.
Table 2 presents a summary of the univariate and bivariate statistics for the whole
sample. Child age predicted significant differences between groups.

Table 2
Univariate and Bivariate Analyses of Child Factors — Overall Sample.
Child
Factor

Not At All
Interested
M (SD)

Slightly/
Somewhat
Interested
M (SD)

Very/
Extremely
Interested
M (SD)

Wilks’
Lambda

df

p

Child Age

4.19 (3.63)

5.08 (3.59)

5.65 (3.67)

.988

2

.018

Note. 652 valid participant responses were included in this analysis, representing 97.2%
of the overall sample.
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Multivariate analyses revealed that the first discriminant function reliably
differentiated among the interest groups (Wilks’s Λ = .988, (2) = 8.07, p = .018 for
discriminant function 1). The discriminant function explained 100% of the variance. The
canonical correlation for DF1 was .111, indicating that 1.2% of the variance in interest
group membership was explained by child age. Table 3 shows the structure weight for the
discriminant function, revealing that child age contributed to the discrimination among
groups, consistent with the bivariate results. The standardized canonical coefficients in
Table 3 reveal that child age had a strong, unique contribution to the function.

Table 3
Structure Weights and Standardized Canonical Coefficients for Child Factors.
Child
Factors
Child Age

Structure
Weights

Standardized Canonical
Coefficients

1.00

1.00

Pairwise comparison of the discriminant function scores indicated differences in
the following pairs: Not At All Interested (M = -.313) vs. Very/Extremely Interested (M
= .089). This indicates that the discriminant function could reliably discriminate parents
who were Not At All Interested from those who were Very/Extremely Interested;
however, this function was unable to reliably discriminate parents who were Not At All
Interested from those who were Slightly/Somewhat Interested or Slightly/Somewhat
Interested from Very/Extremely Interested. Figure 2 provides a graphical depiction of the
multivariate results, and Table 4 shows the predicted interest group classification results
of the discriminant function based on child age. Each show that the discriminant function
performed moderately well at differentiating the parents who reported being Not At All
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Interested in clinical trial participation from parents who reported being Very/Extremely
Interested. However, there was little success differentiating between the Not At all
Interested and Slightly/Somewhat Interested parents or the Slightly/Somewhat Interested
and Very/Extremely Interested parents. Of note, families who reported being Not At All
Interested had younger children overall, while parents who reported being
Very/Extremely Interested had older children.

Figure 2
Graphical Depiction of Group Differentiation based on Child Age.

-1

0
Not At All Interested &
Slightly/Somewhat
Interested
Younger children

1
Very/Extremely Interested
Older Children

Table 4
Group Classification Results based on Child Age.
Interest Group

Not At All
Interested

Slightly/
Somewhat Interested

Not At All Interested
0%
0%
Slightly/Somewhat
0%
0%
Interested
Very/Extremely Interested
0%
0%
Note. 53.4% of original group cases were correctly classified.

Very/
Extremely
Interested
100%
100%
100%

Black Child Factors
Discriminant function analysis was used to determine if child age was able to
predict interest group membership for Black parents. Interest groups included: Not at All
Interested, Slightly/Somewhat Interested, and Very/Extremely Interested in Clinical Trial
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Participation. The mean age of Black children in the sample was 6.49 years with a
standard deviation of 3.52 years. Table 5 presents a summary of the univariate and
bivariate analyses. Child age predicted significant differences between groups.

Table 5
Univariate and Bivariate Analyses of Child Factors — Black Children.
Child
Factors

Not At All
Interested
M (SD)

Slightly/
Somewhat
Interested
M (SD)

Very/
Extremely
Interested
M (SD)

Wilks’
Lambda

df

p

Child Age

5.68 (3.87)

5.67 (3.29)

7.19 (3.48)

.954

2

.008

Note. 218 valid participant responses were included in this analysis, representing 94.8%
of the Black participants.

Multivariate analyses revealed that the discriminant function reliably
differentiated among the interest groups (Wilks’s Λ = .954, (2) = 10.18, p = .006 for
discriminant function 1 through 2). The discriminant function explained 100% of the
variance. The canonical correlation for DF1 was .215, indicating that 4.62% of the
variance in interest group membership for Black parents was explained by child age.
Table 6 shows the structure weight for the discriminant function, revealing that child age
contributed to the discrimination among groups, consistent with the bivariate results. The
standardized canonical coefficient also shown in Table 6 reveal that child age had a
strong, unique contribution to the function.

Table 6
Structure Weights and Standardized Canonical Coefficients for Black Child Factors.
Child
Factors

Structure
Weights

Standardized Canonical
Coefficients
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Child Age

1.00

1.00

Pairwise comparison on the discriminate function scores indicated that differences
were found in the following pairs: Slightly/Somewhat Interested (M = -.238) vs.
Very/Extremely Interested (M = .201). This indicates that the discriminant function
reliably discriminated Black parents who were Slightly/Somewhat Interested from those
who were Very/Extremely Interested; however, the function was unable to reliably
discriminate Black parents who were Not At All Interested from those who were
Slightly/Somewhat Interested or Very/Extremely. Figure 3 provides a graphical depiction
of the multivariate results, and Table 7 shows the result of DF1 used to re-classify Black
parents into their interest groups. Both show that DF1 did moderately well at
differentiating the parents who reported being Slightly/Somewhat Interested in clinical
trial participation from those who reported being Very/Extremely Interested. However,
there was little success in differentiating between Black parents who were Not At all
Interested and those who were Slightly/Somewhat Interested or Very/Extremely
Interested. Of note, Black parents who reported being Not At All or Slightly/Somewhat
Interested had younger children overall, while Black parents who reported being
Very/Extremely Interested had older children.

Figure 3
Graphical Depiction of Group Differentiation based on Child Age – Black Children.
-1

0
Not At All Interested &
Slightly/Somewhat
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Older Children
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Table 7
Group Classification Results based on Child Age – Black Children.
Not At All
Slightly/Somewhat Very/Extremely
Interest Group
Interested
Interested
Interested
Not At All
0%
31.8%
68.2%
Interested
Slightly/Somewhat
0%
28.2%
71.8%
Interested
Very/Extremely
0%
16.9%
83.1%
Interested
Note. 55% of original grouped cases were correctly classified.

White Child Factors
Discriminant analysis was used to determine if child age could predict interest
group membership for White parents. Interest groups included: Not at All Interested,
Slightly/Somewhat Interested, and Very/Extremely Interested in Clinical Trial
Participation. The mean age for White children in this sample was 4.74 years with a
standard deviation of 3.58 years. Table 8 presents a summary of the univariate and
bivariate analyses. Child age predicted significant differences between groups.

Table 8
Univariate and Bivariate Analyses of Child Factors – White Children.
Child
Factors

Not At All
Interested
M (SD)

Slightly/
Somewhat
Interested
M (SD)

Very/
Extremely
Interested
M (SD)

Wilks’
Lambda

df

p

Child
2.62 (2.62)
4.83 (3.69)
4.86 (3.52)
.982
2 .021
Age
Note. 434 valid participant responses were included in this analysis, representing 98.4%
of the White participants.
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Multivariate analyses revealed that the first discriminant function reliably
differentiated among the interest groups (Wilks’s Λ = .982, (2) = 7.76, p = .021 for
discriminant function 1 through 2). The discriminant function explained 100% of the
variance. The canonical correlation for DF1 was .134, indicating that 1.7% of the
variance in interest group membership for White parents was explained by child age.
Table 9 shows the structure weights for the discriminant function, revealing that,
consistent with the bivariate results, child age contributed to the discrimination among
groups. The standardized canonical coefficients also shown in Table 9 reveal that child
age had a strong, unique contribution to the function.

Table 9
Structure Weights and Standardized Canonical Coefficients for White Child Factors.
Child
Structure
Standardized Canonical
Factors
Weights
Coefficients
Child Age

1.00

1.00

Pairwise comparison on discriminant function scores indicated that differences on
DF1 were found in the following pairs: Not At All Interested (M = -.596 ) vs.
Slightly/Somewhat Interested (M = .026), and Not At All Interested (M = -.596 ) vs.
Very/Extremely Interested (M = .034). This indicates that DF1 could reliably
discriminate White parents who were Not At All Interested from those who were
Slightly/Somewhat Interested and Very/Extremely Interested; however, this function was
unable to reliably discriminate Slightly/Somewhat Interested parents from Very/Extremely
Interested parents. Figure 4 provides a graphical depiction of the multivariate results, and
Table 10 shows the result of DF1 used to re-classify White parents into their interest
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groups. Both show that DF1 did moderately well at differentiating White parents who
reported being Not At All Interested in clinical trial participation from White parents who
reported being either Slightly/Somewhat Interested or Very/Extremely Interested in
clinical trial participation. However, there was little success at differentiating between
White parents who reported being Slightly/Somewhat Interested and Very/Extremely
Interested. Of note, White parents who reported being Not At All Interested in clinical
trial participation had younger children overall, while White parents who reported being
Slightly/Somewhat or Very/Extremely Interested had older children.

Figure 4
Graphical Depiction of Group Differentiation based on Child Age – White Children.
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Table 10
Group Classification Results based on Child Age – White Children.
Not At All
Slightly/Somewhat Very/Extremely
Interest Group
Interested
Interested
Interested
Not At All
0%
0%
100%
Interested
Slightly/Somewhat
0%
0%
100%
Interested
Very/Extremely
0%
0%
100%
Interested
Note. 53% of original grouped cases were correctly classified.

Aim 2: Parent Factors
Parent Factors (Overall Sample)
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Discriminant function analysis was used to determine if FA knowledge, parental
self-efficacy, FA quality of life, parental burden, and FAIM scores could predict interest
group membership. Interest groups included: Not at All Interested, Slightly/Somewhat
Interested, and Very/Extremely Interested in clinical trial participation. Table 11 presents
a summary of the univariate and bivariate analyses. Parental FA Knowledge and overall
FAIM score predicted significant differences between groups; however, Parental burden,
Quality of life, and self-efficacy did not.

Table 11
Univariate and Bivariate Analyses of Parent Factors.
Slightly/
Very/
Not At All
Parent
Somewhat
Extremely
Interested
Factors
Interested
Interested
M (SD)
M (SD)
M (SD)

Wilks’
Lambda

df

p

FAQLQ-PB

1.96 (1.33)

2.68 (1.50)

2.43 (1.29)

.982

2

.106

Knowledge

8.18 (3.97)

11.32 (2.54)

11.02 (2.98)

.935

2

<.001

FAQLQPF-10

2.85 (1.35)

3.46 (1.50)

3.69 (1.56)

.980

2

.083

FAIM

2.87 (1.48)

3.59 (1.16)

3.62 (1.18)

.976

2

.048

.998

2

.800

FASE-P

80.26 (17.03)

78.18 (13.48) 78.96 (12.28)

Note. 250 valid participant responses were included in this analysis, representing 37.3%
of the overall sample.

Multivariate analyses revealed that the first discriminant function reliably
differentiated among the interest groups (Wilks’s Λ = .900, (10) = 25.70, p = .004 for
discriminant function 1 through 2); however, the second function did not provide reliable
further differentiation (Wilks’s Λ = .976, (4) = 5.92, p = .205 for discriminant function
2). The first discriminant function explained 77.5% of the variance. The canonical
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correlation for DF1 was .279, indicating that 7.8% of the variance was explained by the
relationship between parent predictors and interest group membership by DF1.
Discriminant function 1 had the largest relationship with FA knowledge, followed by
FAIM, parental burden, FAQLQ-PF, and self-efficacy. Table 12 shows the structure
weights for the first discriminant function, revealing that parental knowledge and FAIM
scores contributed to the discrimination among groups, consistent with the bivariate
results. Inspection of the standardized canonical coefficients also shown in Table 12
reveals that, because of the collinearity amongst other parent factors, only parental FA
knowledge and FAIM scores had a strong, unique contribution to the function.

Table 12
Structure Weights and Standardized Canonical Coefficients for Parent Factors.
Parent Factors

Structure Weights

Standardized
Canonical Coefficients

Knowledge
FAIM
FAQLQ-PF-10
FAQLQ-PB
FASE-P

.908
.538
.404
.392
-.117

.836
.344
.138
.054
.183

Pairwise comparison on DF1 scores indicated that differences on DF1 were found
in the following pairs: Not At All Interested (M = -1.06) vs. Slightly/Somewhat
Interested (M = 0.11) and Not At All Interested (M = -1.06) vs. Very/Extremely
Interested (M = 0.05). This indicates that DF1 could reliably discriminate Not At All
Interested from Slightly/Somewhat Interested and Not At All Interested from
Very/Extremely Interested; however, this function was unable to reliably discriminate
Slightly/Somewhat Interested from Very/Extremely Interested. Figure 5 provides a
graphical depiction of the multivariate results, and Table 13 shows the result of DF1 used
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to reclassify patients into their interest groups. These show that DF1 did very well at
differentiating the parents who reported being Not At All Interested in clinical trial
participation, who reported less FA knowledge and lower FAIM scores than the other two
groups. However, there was little success differentiating between the Slightly/Somewhat
Interested and Very/Extremely Interested parents.

Figure 5
Graphical Depiction of Group Differentiation based on Parent Factors.
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Table 13
Group Classification Results based on Parent Factors.
Not At All
Slightly/Somewhat Very/Extremely
Interest Group
Interested
Interested
Interested
Not At All
17.6%
0%
82.4%
Interested
Slightly/Somewhat
0%
21.4%
78.6%
Interested
Very/Extremely
1.5%
9.6%
88.9%
Interested
Note. 57.6% of original grouped cases were correctly classified.

Black Parent Factors
Discriminant function analysis was used to determine if FA knowledge, parental
self-efficacy, FA quality of life, Parental burden, and FAIM scores could predict interest
group membership for Black parents. Interest groups included: Not at All Interested,
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Slightly/Somewhat Interested, and Very/Extremely Interested in Clinical Trial
Participation. Table 14 presents a summary of the univariate and bivariate analyses.

Table 14
Univariate and Bivariate Analyses of Black Parent Factors.
Slightly/
Very/
Not At All
Parent
Somewhat
Extremely
Interested
Factors
Interested
Interested
M (SD)
M (SD)
M (SD)

Wilks’
Lambda

df

p

FAQLQ-PB

1.88 (1.17)

2.46 (1.48)

1.99 (1.16)

.965

2

.289

Knowledge
FAQLQPF-10
FAIM

9 (2.31)

9.12 (1.86)

8.57 (2.42)

.986

2

.608

3.09 (1.32)

3.78 (1.57)

3.85 (1.75)

.976

2

.423

2.80 (1.39)

3.55 (1.19)

3.41 (1.37)

.967

2

.313

84.05
(13.43)

.955

2

.198

FASE-P

82.87 (14.73) 77.31 (16.37)

Note. 73 valid participant responses were included in this analysis, representing 31.7% of
the Black participants.

Multivariate analyses revealed that neither of the discriminant functions reliably
differentiated among the interest groups (Wilks’s Λ = .877, (10) = 8.93, p = .539 for
discriminant function 1 through 2; Wilks’s Λ = .966, (4) = 2.36, p = .67 for discriminant
function 2). These discriminant functions explained 74.2% and 25.8% of the variance.
The canonical correlation for DF1 and DF2 were .30 and .19, indicating that 9% and
3.6% of the variances were explained by the relationship between predictors and group
membership for DF1 and DF2, respectively. As neither discriminant function was
significant, relationships with individual predictors, structure weights, classification
summaries, and pairwise comparisons were not explored.
White Parent Factors
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Discriminant function analysis was used to determine if FA knowledge, parental
self-efficacy, FA quality of life, Parental burden, and FAIM scores were able to predict
interest group membership for White parents. Interest groups included: Not at All
Interested, Slightly/Somewhat Interested, and Very/Extremely Interested in Clinical Trial
Participation. Table 15 presents a summary of the univariate and bivariate analyses.
Parental FA Knowledge was the only factor that predicted significant differences
between groups; overall FAIM scores, parental burden, quality of life, and self-efficacy
did not.

Table 15
Univariate and Bivariate Analyses of White Parent Factors.
Slightly/
Very/
Not At All
Parent
Somewhat
Extremely
Interested
Factors
Interested
Interested
M (SD)
M (SD)
M (SD)

Wilks’
Lambda

df

p

FAQLQ-PB

2.07 (1.63)

2.75 (1.51)

2.60 (1.31)

.990

2

.428

Knowledge

7 (5.59)

12.11 (2.28)

11.94 (2.63)

.878

2

<.00
1

FAQLQ-PF10

2.49 (1.42)

3.35 (1.47)

3.62 (1.48)

.974

2

.102

FAIM

2.95 (1.72)

3.61 (1.16)

3.69 (1.10)

.984

2

.251

76.52
78.49 (12.39) 77.04 (11.29)
.996
2
.723
(20.49)
Note. 177 valid participant responses were included in this analysis, representing 40.1%
of the White participants.
FASE-P

Multivariate analyses revealed that the first discriminant function reliably
differentiated among the interest groups (Wilks’s Λ = .842, (10) = 29.65, p < .001 for
discriminant function 1 through 2); however, the second function did not provide reliable
further differentiation (Wilks’s Λ = .971, (4) = 5.04, p = .283 for discriminant function
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2). The first discriminant function explained 83.8% of the variance. The canonical
correlation for DF1 was .37, indicating that 13.7% of the variance was explained by the
relationship between White parent predictors and interest group membership by DF1.
Discriminant function 1 had the largest relationship with FA knowledge, followed by
FAQLQ-PF, overall FAIM scores, parental burden, and self-efficacy. Table 16 shows the
structure weights for the first discriminant function, revealing that parental knowledge
contributed to the discrimination among groups, consistent with the bivariate results.
Inspection of the standardized canonical coefficients also shown in Table 16 reveals that
only parental FA knowledge had a strong, unique contribution to the function because of
the collinearity amongst other parent factors.

Table 16
Structure Weights and Standardized Canonical Coefficients for White Parent Factors.
Structure
Standardized Canonical
Parent Factors
Weights
Coefficients
Knowledge
.950
.928
FAQLQ-PF-10
.326
.168
FAIM
.302
.123
FAQLQ-PB
.222
.044
FASE-P
.057
.293

Pairwise comparison on DF1 scores indicates that differences on DF1 were found
in the following pairs: Not At All Interested (M = -1.91) vs. Slightly/Somewhat
Interested (M = 0.11) and Not At All Interested (M = -1.91) vs. Very/Extremely
Interested (M = 0.06). This indicates that DF1 could reliably discriminate Not At All
Interested from Slightly/Somewhat Interested and Not At All Interested from
Very/Extremely Interested; however, this function was unable to reliably discriminate
Slightly/Somewhat Interested from Very/Extremely Interested. Figure 6 provides a
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graphical depiction of the multivariate results, and Table 17 shows the result of DF1 used
to reclassify patients into their interest groups. Both of these show that DF1 did very well
at differentiating the parents who reported being Not At All Interested in clinical trial
participation who reported less FA knowledge from the other two groups. However, there
was little success differentiating between the Slightly/Somewhat Interested and
Very/Extremely Interested parents.

Figure 6
Graphical Depiction of Group Differentiation based on White Parent Factors.

-1
Not At All
Interested
Less FA
Knowledge

0

1
Very/Extremely Interested
& Slightly/Somewhat
Interested
More FA Knowledge

Table 17
Group Classification Results based on White Parent Factors.
Not At All
Slightly/Somewhat Very/Extremely
Interest Group
Interested
Interested
Interested
Not At All
42.9%
28.6%
28.6%
Interested
Slightly/Somewhat
1.4%
27.8%
70.8%
Interested
Very/Extremely
0%
13.3%
86.7%
Interested
Note. 61% of original grouped cases were correctly classified.

Aim 3: Family Factors
Family Factors (Overall Sample)
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Multinomial logistic regression was performed to model the relationship between
the family factors and interest group membership. Family factors included: insurance
type, income, educational attainment, and the number of children in the home with food
allergy. Interest groups included: Not at All Interested, Slightly/Somewhat Interested, and
Very/Extremely Interested in Clinical Trial Participation. The traditional .05 criterion of
statistical significance was employed for all tests. Addition of the predictors to a model
that contained only the intercept did not significantly improve the fit between model and
data, χ2(36, N = 421) = 19.896, Nagelkerke R2 = .055, p = .986. As such, explorations of
unique contributions, Goodness of fit, and parameter estimates were not conducted.
Black Family Factors
Multinomial logistic regression was performed to model the relationship between
the Black family factors and interest group membership. Family factors included:
insurance type, income, educational attainment, and the number of children in the home
with food allergy. Interest groups included: Not at All Interested, Slightly/Somewhat
Interested, and Very/Extremely Interested in Clinical Trial Participation. The traditional
.05 criterion of statistical significance was employed for all tests. Addition of the
predictors to a model that contained only the intercept did not significantly improve the
fit between model and data, χ2(34, N = 148) = 30.314, Nagelkerke R2 = .217, p = .649. As
such, explorations of unique contributions, Goodness of fit, and parameter estimates were
not conducted.
White Family Factors
Multinomial logistic regression was performed to model the relationship between
the White family factors and interest group membership. Family factors included:
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insurance type, income, educational attainment, and the number of children in the home
with food allergy. Interest groups included: Not at All Interested, Slightly/Somewhat
Interested, and Very/Extremely Interested in Clinical Trial Participation. The traditional
.05 criterion of statistical significance was employed for all tests. Addition of the
predictors to a model that contained only the intercept did not significantly improve the
fit between model and data, χ2(34, N = 273) = 42.337, Nagelkerke R2 = .173, p = .154. As
such, explorations of unique contributions, Goodness of fit, and parameter estimates were
not conducted.
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Discussion

Clinical trials are essential for evaluating the safety, efficacy, and acceptability of
novel treatment modalities. Health researchers aim to recruit representative samples that
reflect the full diversity of the affected population, and account for unique phenotypes
and endotypes. Considering the decision to enroll a child in a clinical trial may be
difficult for parents, therefore it is important to carefully evaluate the various factors that
may influence their treatment-related decisions. To date, this is the first study of its kind
to evaluate the effect of child, parent, and family-level factors on parental interest in
clinical trial participation for the treatment of pediatric food allergy.
Examination of child factors revealed that child age uniquely predicted parental
interest in clinical trial participation. Consistent with previous research (Hoberman et al.,
2013; Sureshkumar et al., 2012), the present study found that parents of older children
were more interested in clinical trial participation than parents of younger children. These
findings are particularly timely as recent studies have identified similar trends in COVID19 vaccine research. Specifically, research in this area suggests parents of older children
are more willing to enroll their children in clinical trials of the COVID-19 vaccine
(Goldman et al., 2020, 2021). Thus, researchers must carefully consider how to address
the potential concerns and motivations of parents of younger children, in order to enroll
the full age spectrum of the affected population.
Additionally, the significance of child age and its ability to differentiate between
interest groups varied by race. On average Black children in this study were slightly older
than White children. This finding can be partially understood in the context of other
studies citing under-diagnosis and/or inadequate access to specialty care for FA among
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urban minority children, contributing to increased age at the time of initial diagnosis
(Mahdavinia et al., 2017; Taylor-Black & Wang, 2012). Interestingly, there was a small
difference in the percentage of the variance in interest group membership explained by
child age between Black and White parents, suggesting child age may play a greater role
Black parent’s decision-making process.
In the overall sample, child age reliably differentiated parents who reported being
not at all interested in clinical trial participation from parents who were very/extremely
interested. However, child age alone was unable to reliably differentiate parents who
were Not At All Interested from those who were Slightly/Somewhat Interested or
Slightly/Somewhat Interested from Very/Extremely Interested.
Similar to the overall sample, child age reliably differentiated White parents who
reported being Not At All Interested in clinical trial participation from White parents who
reported being either Slightly/Somewhat Interested or Very/Extremely Interested in
clinical trial participation. However, among White parents, child age alone was unable to
reliably differentiate White parents who reported being Slightly/Somewhat Interested
from those who were Very/Extremely Interested. The slight nuance in the difference
between White parents and the overall sample might be explained by the removal of
Black respondents from this analysis, and the results of the overall sample may be a more
accurate representation. Additionally, child age reliably differentiated Black parents who
were Slightly/Somewhat Interested from those who were Very/Extremely Interested, but
was unable to reliably differentiate Black parents who were Not At All Interested from
those who were Slightly/Somewhat Interested or Very/Extremely. This finding could be in
part due to the relatively small number of Black respondents who reported being Not At
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All Interested in clinical trial participation. Despite these marginal differences, child age
remained a notable factor that influenced interest in clinical trial participation among all
families included in the study.
Regarding parent factors, FA knowledge and parents’ perceived risk of adverse
FA outcomes significantly predicted interest in clinical trial participation. Parents who
reported less FA knowledge and less perceived risk of adverse FA outcomes were less
interested in clinical trial participation. At present, this is the first study to elucidate the
effect of condition-specific knowledge and perceived outcome risk on interest in clinical
trial participation for parents of food-allergic children.
Interestingly, race effects were evident in this study. Among White parents, FA
knowledge was the only reliable predictor of interest in clinical trial participation, but
perceived risk of adverse FA outcomes was no longer significant. This finding suggests
that White parents are influenced more by FA knowledge alone when considering
whether or not to participate in a clinical trial. As such, White parents who report less
FA knowledge may require specific interventions to increase their knowledge before they
consider enrolling their child in a clinical trial.
On the other hand, among Black parents, none of the parent variables examined
were reliable predictors of interest in clinical trial participation. In other words, interest in
clinical trial participation does not seem to be about knowledge or perceived risk of
adverse FA outcomes for Black parents. Literature has shown that poor and workingclass Black individuals have a different relationship with the medical field (George et al.,
2014). In a systematic review of barriers to minority research participation, researchers
highlighted five distinct barriers to health research participation among Black Americans,
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all of which fell under the umbrella of a legacy of distrust (George et al., 2014). These
themes included: knowledge of the Tuskegee Study (Shavers et al., 2002), lack of
research integrity (Corbie-Smith et al., 2002; Freimuth et al., 2001; Slomka et al., 2008),
a legacy of racism and discrimination in the healthcare system (Kaluzny et al., 1993), and
concerns with the research process (Farmer et al., 2007).
In addition to distrust, the perception of risk involved with clinical trials (Ding et
al., 2007) and the associated fear of research participation (Katz et al., 2006) have also
been recognized in the literature as impeding factors to clinical trial enrollment for Black
Americans. Although past research has found that Black Americans perceive greater risk
involved in clinical trial participation (Braunstein et al., 2008; Kim et al., 2015), this was
not directly explored in the present study. This study suggests that interest in clinical trial
participation for Black parents may be influenced by factors not considered in the present
study. Inevitably, there is more to be explored to determine what helps Black parents
make decisions related to treatment options for their food-allergic children.
Lastly, and contrary to our study hypothesis, no family factors were reliable
predictors of interest in clinical trial participation. The variables included for the family
analyses did not appear to affect parents’ decision-making regarding interest in clinical
trials. This pattern of null relationships was also observed across racial groups. Although
this aim was not supported in the present analysis, it provides valuable insight into what
families may consider more strongly when evaluating treatment options. In the present
study, insurance status, educational attainment, and income were used as proxy indicators
of socioeconomic status due to their known associations with clinical trial participation in
other populations (Hoberman et al., 2013; Svensson et al., 2012). Additionally, past
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research has identified disparate clinical trial participation rates among families living in
poverty (Ni et al., 2016). However, the mechanisms that could lead to these findings are
complex and multidimensional. Experiencing socioeconomic disadvantage can result in
several pragmatic barriers to research participation (e.g., lack of childcare and inability to
miss work). As such, studies have reported that intervention research requiring active
caregiver participation has lower recruitment and retention rates than solely child-focused
studies (Cui et al., 2015). Thus future studies should explore the effect of pragmatic
barriers on clinical trial interest and participation in the food allergy population.
Limitations & Future Directions
The current study had several limitations that should be considered. First, the
study examined interest in clinical trial participation as the outcome variable and not
actual enrollment. Data on actual clinical trial enrollment (i.e., whether families followed
through on that interest) was unavailable and those a gap exists that cannot be explained
by the current study. This difference between interest and actual enrollment may depend
largly on demographic and economic variables. For example, in the event a parent does
not have the resources to travel to a trial or take off work to participate, they may report
interest in enrollment but not follow through with actual enrollment because of these
barriers. As such, it is not possible to extrapolate the findings of the present study to
predict actual clinical trial enrollment.
Additionally, the present study had a small number of participants who reported
not being interested in clinical trial participation. Future qualitative studies should target
these individuals specifically to get richer data about what drives their decision-making.
Learning about the individuals who decline to participate, or express a lack of interest in
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clinical trials altogether, would be valuable information for clinicians and researchers.
Aspects of clinical trials themselves may create practical barriers to clinical trial
participation that are not yet explored. Thus, gathering qualitative information could help
providers understand if patient and family decision-making is based on the characteristics
of the study itself.
Further, considering the decision to participate in clinical trials is dichotomized
(i.e., consent or decline to consent), it is also important to understand individuals' reasons
for declining to participate in these studies. For instance, what factors influence their
actual decision for families who express interest in trial participation but decline to
participate. Qualitative research could provide greater insight into the potential barriers
between interest and actual participation. Therefore future studies should employ
qualitative methods to explore the subjective elements influencing parents' decisions to
participate in clinical trials.
Second, the present study found that child age is an important factor for both
White and Black families in predicting interest in clinical trial participation for pediatric
food allergy. As children age, their caregivers may have different values and beliefs
about care decisions. However, child age alone accounted for a very small amount of the
variance explained making it a considerable limitation. Given the small variance in
interest group membership explained by child age, future studies should explore
additional child factors that may influence parental interest in clinical trial participation.
Additional factors may include condition severity, child gender, and perceived capacity
for shared decision-making.
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Third, parental FA knowledge was also a salient factor for White parents.
However, the FA knowledge measure used in the present study narrowly focused on the
condition itself and its management, thereby limiting the ability to assess parental
knowledge more broadly. Previous studies suggest that parental understanding of basic
clinical research concepts and the research process itself can influence their medical
decision-making (Cousino et al., 2018; Kim et al., 2015; Kodish et al., 2004). Thus,
future studies should explore how knowledgeable parents are about clinical trials
themselves to determine where psychoeducation can support the optimal recruitment of
diverse research samples.
Finally, none of the demographic variables emerged as important factors in
predicting interest, suggesting that prior assumptions about lack of participation due to
these factors may not be entirely correct, at least in the United States. Future studies
should incorporate these findings and address these issues to improve clinical trial
enrollment and equitable participation of diverse samples in food allergy clinical trial
research. One consideration is to explore parents subjective social status, which has been
identified as a better indicator of health behavior change compared to income, education,
or insurance status alone (Adler, 2009).
Although there were limitations, the results of this study suggest some important
avenues for future research on clinical trial participation in pediatric food allergy. This
translational study significantly advances decision science, addresses existing disparities,
and can have far-reaching clinical implications. Specifically, this project attended to two
fundamental issues in the FA literature: 1) What considerations do parents of food
allergic children make when evaluating treatment options, and 2) how can healthcare
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professionals improve the generalizability of clinical findings through recruitment of
diverse research samples? Furthermore, this study was unique in that it leveraged
pediatric medical decision-making literature from other conditions to examine the extent
to which different levels within a family system interact to influence treatment-related
decision-making and health management for FA. As such, this focus improves our
understanding of the factors that influence parent’s FA-related medical decision
processes, and the mechanisms that contribute to existing disparities in health research
participation. In turn, this study has the potential to inform research practices and future
clinical guidelines aimed at recruiting representative samples and achieving health equity.
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